NDC 57293-4419

Lymphohepat

Arsenic Trioxide, Calendula Officinalis Flowering Top, Milk Thistle, Chelidonium Majus, Marsdenia Condurango Bark, Echinacea, Unspecified, Goldenseal, Veronicastrum Virginicum Root, Lycopodium Clavatum Spore, Phytolacca Americana Root, Sanguinaria Canadensis Root, Taraxacum Palustre Root

Lymphohepat is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Bioenergetics, Inc.. The primary component is Arsenic Trioxide; Calendula Officinalis Flowering Top; Milk Thistle; Chelidonium Majus; Marsdenia Condurango Bark; Echinacea, Unspecified; Goldenseal; Veronicastrum Virginicum Root; Lycopodium Clavatum Spore; Phytolacca Americana Root; Sanguinaria Canadensis Root; Taraxacum Palustre Root.

Product ID57293-4419_6866cdc1-b47a-32dc-e053-2991aa0a1db2
NDC57293-4419
Product TypeHuman Otc Drug
Proprietary NameLymphohepat
Generic NameArsenic Trioxide, Calendula Officinalis Flowering Top, Milk Thistle, Chelidonium Majus, Marsdenia Condurango Bark, Echinacea, Unspecified, Goldenseal, Veronicastrum Virginicum Root, Lycopodium Clavatum Spore, Phytolacca Americana Root, Sanguinaria Canadensis Root, Taraxacum Palustre Root
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1993-02-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBioEnergetics, Inc.
Substance NameARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; MILK THISTLE; CHELIDONIUM MAJUS; MARSDENIA CONDURANGO BARK; ECHINACEA, UNSPECIFIED; GOLDENSEAL; VERONICASTRUM VIRGINICUM ROOT; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SANGUINARIA CANADENSIS ROOT; TARAXACUM PALUSTRE ROOT
Active Ingredient Strength12 [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 57293-4419-2

60 mL in 1 BOTTLE, GLASS (57293-4419-2)
Marketing Start Date1993-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 57293-4419-2 [57293441902]

Lymphohepat LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1993-02-01

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.